Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6733185 | 7368432 | F | 6733185-2 | 20100420 | 20100518 | 20100520 | PER | US-BIOGENIDEC-2010BI013829 | BIOGEN IDEC INC. | 22 | YR | M | Y | 20100520 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6733185 | 1013718669 | PS | TYSABRI | 1 | INTRAVENOUS | ||||||
| 6733185 | 1013718670 | SS | TYSABRI | 1 | INTRAVENOUS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6733185 | 1013718669 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6733185 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6733185 | INFLUENZA LIKE ILLNESS |
| 6733185 | MULTIPLE SCLEROSIS RELAPSE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6733185 | 1013718670 | 20100420 |